for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. FDA expands use of CDC coronavirus diagnostic test

Feb 4 (Reuters) - The U.S. Food and Drug Administration on Tuesday extended the use of a coronavirus detection tool to Centers for Disease Control and Prevention (CDC)-qualified laboratories across the country.

The authorization was until recently limited to CDC laboratories.

Under the emergency use authorization, the 2019-nCoV Real-Time RT-PCR diagnostic panel can be used in patients who meet the CDC criteria for coronavirus testing.

“Negative results do not preclude 2019-nCoV infection and should not be used as the sole basis for treatment or other patient management decisions,” the FDA said.

Reporting by Dania Nadeem in Bengaluru; Editing by Shinjini Ganguli

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up